GT199900083A - Combinaciones terapeuticas para la fragilidad musculoesqueletica. - Google Patents

Combinaciones terapeuticas para la fragilidad musculoesqueletica.

Info

Publication number
GT199900083A
GT199900083A GT199900083A GT199900083A GT199900083A GT 199900083 A GT199900083 A GT 199900083A GT 199900083 A GT199900083 A GT 199900083A GT 199900083 A GT199900083 A GT 199900083A GT 199900083 A GT199900083 A GT 199900083A
Authority
GT
Guatemala
Prior art keywords
fragility
therapeutic combinations
reduction
procedures
musculoskeletal
Prior art date
Application number
GT199900083A
Other languages
English (en)
Spanish (es)
Inventor
Hua Zhu Ke
Mei Li
Lidia Codetta Pan
David Duane Thompson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199900083A publication Critical patent/GT199900083A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
GT199900083A 1998-06-16 1999-06-14 Combinaciones terapeuticas para la fragilidad musculoesqueletica. GT199900083A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
GT199900083A true GT199900083A (es) 2000-12-05

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900083A GT199900083A (es) 1998-06-16 1999-06-14 Combinaciones terapeuticas para la fragilidad musculoesqueletica.

Country Status (29)

Country Link
EP (1) EP1085867A1 (ja)
JP (1) JP2002518328A (ja)
KR (1) KR20010052817A (ja)
CN (1) CN1305378A (ja)
AP (1) AP9901581A0 (ja)
AR (1) AR018868A1 (ja)
AU (1) AU3342099A (ja)
BG (1) BG105128A (ja)
BR (1) BR9911357A (ja)
CA (1) CA2335112A1 (ja)
CO (1) CO5070586A1 (ja)
EA (1) EA200001189A1 (ja)
GT (1) GT199900083A (ja)
HR (1) HRP20000857A2 (ja)
HU (1) HUP0102395A2 (ja)
ID (1) ID26726A (ja)
IL (1) IL139587A0 (ja)
IS (1) IS5727A (ja)
MA (1) MA26648A1 (ja)
NO (1) NO20006381D0 (ja)
OA (1) OA11569A (ja)
PA (1) PA8472101A1 (ja)
PE (1) PE20000633A1 (ja)
PL (1) PL345064A1 (ja)
SK (1) SK18902000A3 (ja)
TN (1) TNSN99118A1 (ja)
UY (1) UY25557A1 (ja)
WO (1) WO1999065488A1 (ja)
ZA (1) ZA993973B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
CA2420535A1 (en) * 2000-08-30 2002-03-07 Mary Tanya Am Ende Sustained release formulations for growth hormone secretagogues
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
DK1460969T3 (da) * 2001-11-29 2008-09-01 Gtx Inc Forebyggelse og behandling af ved androgen-berövelse fremkaldt osteoporose
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
EP2118080B1 (en) 2007-02-09 2016-08-31 Ocera Therapeutics, Inc. Macrocyclic ghrelin receptor modulators and methods of using the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (uk) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
AP9901581A0 (en) 1999-06-30
CN1305378A (zh) 2001-07-25
EP1085867A1 (en) 2001-03-28
CO5070586A1 (es) 2001-08-28
BR9911357A (pt) 2001-03-13
HUP0102395A2 (hu) 2001-11-28
AR018868A1 (es) 2001-12-12
AU3342099A (en) 2000-01-05
ID26726A (id) 2001-02-01
PE20000633A1 (es) 2000-07-26
HRP20000857A2 (en) 2001-10-31
OA11569A (en) 2004-07-01
IL139587A0 (en) 2002-02-10
UY25557A1 (es) 2001-01-31
EA200001189A1 (ru) 2001-06-25
NO20006381L (no) 2000-12-14
PL345064A1 (en) 2001-11-19
CA2335112A1 (en) 1999-12-23
PA8472101A1 (es) 2000-09-29
JP2002518328A (ja) 2002-06-25
TNSN99118A1 (fr) 2005-11-10
SK18902000A3 (sk) 2001-12-03
KR20010052817A (ko) 2001-06-25
WO1999065488A1 (en) 1999-12-23
BG105128A (en) 2001-11-30
IS5727A (is) 2000-11-24
ZA993973B (en) 2000-12-15
MA26648A1 (fr) 2004-12-20
NO20006381D0 (no) 2000-12-14

Similar Documents

Publication Publication Date Title
PA8493701A1 (es) Compuestos para tratar la obesidad
CR7716A (es) Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor
UY28945A1 (es) Derivados de pirrolopiridina
UY29265A1 (es) Compuestos de 3h-oxazolo y 3h-tiazolo(4,5,-d)pirimidin-2-ona 3,5- disustituidos y 3,5,7-trisustituidos y sus profármacos
UY29796A1 (es) Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
UY27350A1 (es) Azaindoles
ECSP045069A (es) Uso de flibanserina en el tratamiento de trastornos sexuales
BRPI0414867A (pt) pirazolopiridinas e seus análogos
DK1309589T3 (da) Ureaforbindelser og anvendelsesfremgangsmåder
ES2064130T3 (es) Utilizacion de droloxifeno para el tratamiento de enfermedades de los huesos.
UY28931A1 (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
PT1259512E (pt) Compostos de pteridin para o tratamento da psoriase
ECSP034810A (es) Derivados heterociclilalcoxi-, -alquiltio- y - alquilaminobenzazol tales como ligandos 5-hidroxitriptamina-6
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
PA8635901A1 (es) Nucleosidos de 3-beta-d-ribofuranosiltiazolo [4,5-d] pirimidina y usos de los mismos
CO5611124A2 (es) Derivados de benzofurano substituidos utiles en el tratamiento de desordenes hiper-proliferativos
ECSP055958A (es) 4-aminopirimidina-5-ona
CL2011002766A1 (es) Compuestos derivados de carboxamida, inhibidores de calpaina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas, alzahimer, dolor, entre otras.
GT199900083A (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica.
UY28535A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
UY27324A1 (es) Nuevas sales de napsilato i
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
DE602004009166D1 (de) Neue Analoga von Nitrobenzylthioinosin
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.